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Abstract
Introduction:  Clostridium  difficile  is  the  first  cause  of  healthcare-associated  diarrhea  in  devel-
oped countries.  In  recent  years  the  incidence  of  C.  difficile  infection  (CDI)  has  increased
worldwide.  There  is  not  much  information  on  the  topic  in  Mexico,  and  little  is  known  about
the risk  factors  for  the  infection  in  patients  that  are  hospitalized  in  surgical  services.
Materials  and  methods:  A  case-control  study  was  conducted  that  compared  the  epidemiologic
findings and  risk  factors  between  surgical  patients  with  PCR-confirmed  CDI,  surgical  patients
with diarrhea  and  a  negative  PCR  test,  and  surgical  patients  with  no  diarrhea.  The  statistical
analysis was  carried  out  using  the  SPSS  version  22.0  program.
Results:  The  majority  of  the  surgical  patients  with  CDI  belonged  to  the  areas  of  neurosurgery,
cardiac surgery,  orthopedics,  and  general  surgery.  A  total  of  53%  of  the  CDI  cases  were  associated
with the  hypervirulent  CD  NAP1/027  strain.  The  presence  of  mucus  in  stools  (OR:  1.5,  p  =  0.001),
fever (OR:  1.4,  p  =  0.011),  leukocytes  in  stools  (OR:  3.2,  p  <  0.001),  hospitalization  within  the
past twelve  weeks  (OR:  2.0,  p  <  0.001),  antibiotic  use  (OR:  1.3,  p  =  0.023),  and  ceftriaxone  use
(OR: 1.4,  p  =  0.01)  were  independent  risk  factors  for  the  development  of  CDI.
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Conclusions:  C.  difficile-induced  diarrhea  in  the  surgical  services  is  frequent  at  the  Hospital
Civil de  Guadalajara  ‘‘Fray  Antonio  Alcalde’’.
© 2019  Asociacio´n  Mexicana  de  Gastroenterolog´ıa.  Published  by  Masson  Doyma  Me´xico  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Resumen
Introducción:  Clostridium  difficile  (CD)  es  la  primera  causa  de  diarrea  asociada  al  cuidado  de
salud en  los  países  desarrollados.  En  los  últimos  an˜os,  la  incidencia  de  la  infección  asociada  a
C. difficile  (ICD)  ha  aumentado  en  el  ámbito  mundial.  En  México,  la  información  al  respecto
es escasa,  y  se  conoce  poco  sobre  los  factores  de  riesgo  para  esta  enfermedad  en  pacientes
hospitalizados  en  servicios  quirúrgicos.
Material  y  métodos:  Estudio  de  casos  y  controles.  Se  compararon  hallazgos  epidemiológicos  y
factores de  riesgo  entre  pacientes  quirúrgicos  con  ICD  confirmada  por  PCR  contra  pacientes
quirúrgicos  con  diarrea  PCR  negativa  y  contra  pacientes  quirúrgicos  sin  diarrea.  Se  realizó
análisis  estadístico  mediante  el  paquete  estadístico  SPSS  versión  22.0.
Resultados:  La  mayoría  de  los  pacientes  quirúrgicos  con  ICD  correspondían  a  las  áreas  de  neu-
rocirugía, cardiocirugía,  ortopedia  y  cirugía  general.  El  53%  de  los  casos  de  ICD  se  asociaron  a  la
cepa hipervirulenta  de  CD  NAP1/027.  La  presencia  de  moco  en  heces  (RM  1.5,  p  =  0.001),  fiebre
(RM 1.4,  p  =  0.011),  leucocitos  en  heces  (RM  3.2,  p=<0.001),  hospitalización  en  las  últimas  doce
semanas  (RM  2.0,  p=<0.001),  uso  de  antibióticos  (RM  1.3,  p  =  0.023)  y  uso  de  ceftriaxona  (RM
1.4, p  =  0.01)  constituyeron  factores  de  riesgo  independientes  para  el  desarrollo  de  ICD.
Conclusiones:  La  diarrea  por  CD  en  servicios  quirúrgicos  es  frecuente  en  nuestra  institución
(Hospital Civil  de  Guadalajara  ‘‘Fray  Antonio  Alcalde’’).
© 2019  Asociacio´n  Mexicana  de  Gastroenterolog´ıa.  Publicado  por  Masson  Doyma  Me´xico  S.A.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Sntroduction and aims
lostridioides  difficile  infection  (CDI)  is  the  main  cause  of
ealthcare-associated  diarrhea  and  is  the  most  frequent
ause  in  certain  countries.1
In  a  1986  case-control  study,  the  authors  reported  that
7%  of  CDIs  were  hospital-acquired,  and  75%  of  them
ere  in  patients  in  the  surgical  services.  The  risk  factors
ncluded  having  a  previous  infection,  multiple  antibiotic
se,  especially  clindamycin,  prior  to  the  appearance  of  CDI,
nd  prolonged  hospitalization.2 Olson  et  al.  reported  that
pproximately  half  of  the  patients  with  CDI  belonged  to  a
urgical  service.3
In  recent  years,  different  researchers  on  surgery
escribed  the  presence  of  CDI  in  surgical  patients  after  col-
rectal  resection  (2.2%),  with  important  variations  between
ifferent  surgeons  and  hospitals,4 reporting  an  incidence  of
.8%  after  ileostomy.5
The  burden  of  CDI  in  surgery  has  been  reported  in  dif-
erent  countries:  21,371  general  surgery  patients  (0.47%)  in
he  United  Kingdom;  19  out  of  4,720  patients  (0.4%)  in  Korea;
43,652  surgical  procedures  (0.28%)  in  Japan;  and  2,581  out
f  349,122  patients  (0.75%)  in  the  United  States,  as  well
s  35,363  patients  (0.51%)  after  40  types  of  surgery  in  52
ospitals.6--10The  real  burden  of  CDI  in  hospital  surgical  areas  is  not
pecifically  described  in  the  majority  of  reports  published
n  C.  difficile,  but  that  does  not  mean  those  patients  were
ot  affected  by  the  pathology.
T
o
u
hIn  the  relation  between  prophylactic  antibiotic  admin-
stration  in  surgical  patients  to  its  association  as  a  risk
actor  for  developing  CDI,  there  is  also  an  increased  risk
or  infection  due  to  the  hypervirulent  C.  difficile  NAP1/027
train.11,12
im
he  aim  of  the  present  study  was  to  analyze  the  risk  fac-
ors  for  acquiring  CDI  in  patients  hospitalized  in  the  surgical
ervices  at  the  Hospital  Civil  de  Guadalajara  Fray  Antonio
lcalde.
aterials and methods
tudy  site
he  present  study  was  conducted  at  the  Hospital  Civil  de
uadalajara  Fray  Antonio  Alcalde,  a  tertiary  care  univer-
ity  hospital  with  890  long-stay  hospital  beds,  located  in
uadalajara,  Jalisco.
tudy  designhe  case-control  study  was  carried  out  within  the  time  frame
f  December  2013  to  September  2016.  A  prospective  follow-
p  was  conducted  on  all  cases  of  diarrhea  found  at  our
ospital.  The  study  focused  on  patients  in  the  surgical  wards,
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Table  1  Surgical  service  distribution  of  the  cases  and  controls.
CDI  Diarrhea  and  negative  PCR  (controls-1)  No  diarrhea  (controls-2)
n  %  n  %  n  %
Neurosurgery  41  33.4  113  37.5  74  29.6
Cardiac surgery  23  18.7  25  8.3  37  14.8
Orthopedics  19  15.4  43  14.3  61  24.4
General surgery  19  15.4  74  24.6  43  17.2
Urology 8  6.5  7  2.3  8  3.2
Plastic surgery 4  3.3  7  2.3  2  0.8
Transplantation 4  3.3  22  7.3  3  1.2
Coloproctology  3  2.4  2  0.7  9  3.6
Ophthalmology  1  0.8  0  0  1  0.4
Oncosurgery  1  0.8  3  1  5  2
Gynecology  0  0  5  1.7  5  2
Otorhinolaryngology  0  0  0  0  2  0.8
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sidentifying  the  study  subjects  as  surgical  cases  with  diar-
rhea  and  a  positive  PCR  test  for  C.  difficile  (Cepheid  Xpert
C.  difficile/Epi  Cepheid,  Sunnyvale  CA),  surgical  cases  with
diarrhea  and  a  negative  PCR  test  (controls-1),  and  surgi-
cal  cases  with  no  diarrhea  that  were  in  the  same  wards
for  the  same  period  of  time  (controls-2).  Demographic,  epi-
demiologic,  and  clinical  data  were  obtained.  The  study  was
approved  by  the  Research  and  Ethics  Committee  of  the  Hos-
pital  Civil  de  Guadalajara. All  patients  signed  statements  of
informed  consent  that  were  authorized  by  the  Ethics  Com-
mittee.
Definitions
Healthcare-associated  diarrhea  was  defined  by  the  presence
of  stools  with  a  consistency  matching  the  Bristol  scale  type
5  to  7,  with  3 or  more  bowel  movements  in  24  h,  after  48  h
of  hospital  admission  (Mexican  Official  Norm  NOM-017-SSA2-
2012,  for  epidemiologic  surveillance).  CDI  was  defined  as
healthcare-associated  diarrhea  with  a  positive  PCR  analysis
for  C.  difficile.
Statistical  analysis
Specific  univariate  descriptive  statistics  for  the  surgical
services  were  carried  out,  including  the  epidemiologic
and  clinical  characteristics  of  the  study  population.  The
dichotomous  variables  were  expressed  as  frequencies  and
percentages,  and  the  quantitative  variables  as  medians  and
ranges.  The  bivariate  comparison  analysis  between  groups
was  performed  using  the  chi-square  test  for  the  qualitative
variables  and  the  Mann-Whitney  U  test  for  the  quantitative
variables.  The  risk  factors  were  determined  by  submit-
ting  the  variables  with  a  probability  of  0.20  or  lower,
which  were  then  adjusted  to  a  linear  regression  model.
The  SPSS  version  22.0  was  utilized  to  carry  out  the  sta-
tistical  analysis  and  statistical  significance  was  set  at  a
p  <  0.05.
(
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T
dthical  considerations
he  present  study  was  approved  by  the  Research  and  Ethics
ommittee  of  the  Hospital  Civil  de  Guadalajara. All  patients
igned  statements  of  informed  consent  and  patient  data
emained  confidential  and  anonymous,  following  the  pro-
ocols  of  our  work  center.
esults
he  majority  of  the  123  surgical  cases  with  CDI  were  in  the
ervices  of  neurosurgery,  cardiac  surgery,  orthopedics,  and
eneral  surgery.  Eighty-five  percent  of  all  the  surgical  cases
n  those  services  were  registered  with  diarrhea  and  nega-
ive  PCR  testing,  and  86%  were  registered  with  no  diarrhea
Table  1).
A total  of  123  surgical  cases  with  CDI  were  detected,
long  with  301  surgical  cases  with  diarrhea  and  a  nega-
ive  PCR  analysis,  and  255  surgical  cases  with  no  diarrhea
Table  2).  The  presence  of  leukocytes  (≥12,000  cell/mm3),
lbumin  (under  3  g/dl),  hospitalization  (more  than  7  days),
ospitalization  within  the  last  12  weeks,  immunosuppres-
ant  use,  antibiotic  use,  and  meropenem  and  fluconazole  use
ere  more  frequent  in  surgical  patients  with  CDI  than  in  sur-
ical  patients  with  no  diarrhea  (p  <  0.001).  In  addition,  the
resence  of  leukocytes  in  stools  was  more  frequent  in  surgi-
al  patients  with  CDI  than  in  surgical  patients  with  diarrhea
nd  a  negative  PCR  test  (p  <  0.001)  (Table  2).
Surgical  patients  with  CDI  with  the  C.  difficile  NAP1/027
train  had  higher  levels  of  bloody  stools  (p  =  0.042)  and
reater  use  of  immunosuppressants  (p  =  0.021)  and  amikacin
p  =  0.035)  than  the  surgical  patients  infected  with  other  C.
ifficile  ribotypes  (Table  3).
In  the  multivariate  analysis,  the  presence  of  mucus  in
tools  (p  = 0.001),  fever  (p  = 0.011),  leukocytes  in  stools
p  <  0.001),  hospitalization  within  the  past  12  weeks
p  <  0.001),  antibiotic  use  (p  =  0.023),  and  ceftriaxone  use
p  =  0.01)  were  independent  risk  factors  for  developing  CDI.
igecycline  use  was  greater  in  the  surgical  controls  with
iarrhea  and  a  negative  PCR  analysis  (p  =  0.011)  (Table  4).
230  R.  Morfín-Otero  et  al.
Table  2  Demographic  and  clinical  characteristics  of  the  cases  and  controls.
Variable  Surgical  patients
with  CDI  (n  =  123)
Surgical  patients
with  diarrhea
and  negative  PCR
(controls-1)
(n  =  301)
p  Surgical
patients  with
no  diarrhea
(controls-2)
(n =  250)
p
Demographic  characteristics
Median  age  (range)  45  (15-83)  45  (15-93)  0.768  45  (15-94)  0.994
Male, n  (%)  91  (74)  212  (70.4)  0.462  154  (61.6)  0.018
Female, n  (%)  32  (26)  89  (29.6)  96  (38.4)
Clinical manifestations
Bloating,  n  (%)  51  (41.5)  104  (34.6)  0.180  NA  NA
Vomiting, n  (%) 15  (12.2) 44  (14.6) 0.513  NA  NA
Abdominal pain,  n  (%)  53  (43.1)  116  (38.5)  0.190  NA  NA
Fever, n  (%)  47  (38.2)  75  (24.9)  0.006  NA  NA
Laboratory studies
Mucus  in  stools,  n  (%)  47  (38.2)  93  (30)  0.146  NA  NA
Bloody stools,  n  (%) 8  (6.5)  20  (6.6)  0.958  NA  NA
Creatinine above  1.5  (mg/dL),  n  (%) 104  (84.6) 247  (82.1)  0.537  17  (6.8)  0.008
Leukocytes in  stools,  n  (%) 86  (69.9)  144  (47.8)  <0.001  NA  NA
Leukocytes (≥12  000/mm3),  n  (%) 61  (49.6) 138  (45.8)  0.483  60  (24)  <0.001
Risk factors
Albumin  below  3  g/dl,  n  (%) 71  (57.7) 165  (54.8)  0.585  55  (22)  <0.001
Age (above  64  years),  n  (%) 26  (21.1) 64  (21.3) 0.977  57  (22.8)  0.717
Hospitalization,  (above  7  days)  n  (%) 27  (22) 65  (21.6) 0.912  104  (41.6)  <0.001
Hospitalization  in  the  last  12  weeks  n,  (%) 41  (33.3) 79  (26.2) 0.142  30  (12)  <0.001
Intensive care  unit  stay,  n  (%) 18  (14.6) 63  (20.9) 0.876  14  (5.6)  0.003
Comorbidities,  n  (%) 79  (64.2) 190  (63.1) 0.830  190  (63.1)  0.830
Kidney failure,  n  (%)  14  (4.7)  37  (12.3)  0.794  12  (4.8)  0.019
Diabetes mellitus,  n  (%)  35  (28.5)  68  (22.6)  0.201  44  (17.6)  0.016
Autoimmune disease,  n  (%)  3  (2.4)  3  (1)  0.254  0  (0)  0.013
High blood  pressure,  n  (%)  35  (28.5)  74  (24.6)  0.408  56  (22.4)  0.200
Cirrhosis of  the  liver,  n  (%)  1  (0.8)  8  (1.0)  0.859  4  (1.6)  0.534
Solid tumor,  n  (%)  12  (9.8)  23  (7.6)  0.473  24  (9.6)  0.962
Pneumonia, n  (%)  14  (11.4)  45  (15)  0.335  19  (7.6)  0.227
Pancreatitis, n  (%)  1  (0.8)  9  (3.0)  0.180  5  (2.0)  0.392
Abdominal surgery,  n  (%)  29  (23.6)  116  (38.5)  0.003  60  (24)  0.928
Previous surgery,  n  (%)  84  (68.3)  226  (75.1)  0.152  156  (62.4)  0.717
Medications
Proton pump  inhibitors  111  (90.2)  253  (84.1)  0.097  197  (78.8)  0.006
Immunosuppressants  18  (14.6)  33  (11)  0.292  11  (4.4)  0.001
Chemotherapy  (6  weeks  earlier)  3  (24)  1  (0.3)  0.042  1  (0.4)  0.072
Antibiotic use  96  (78)  211  (70.1)  0.097  146  (58.4)  <0.001
More than  5  days  of  antibiotics  53  (43.1)  89  (26.6)  0.098  10  (4)  <0.001
Tigecycline 4  (3.3)  33  (11)  0.011  9  (3.6)  0.863
Colistin 4  (3.3)  6  (2)  0.438  2  (0.8)  0.077
Clindamycin 33  (26.8)  51  (16.9)  0.020  45  (18)  0.049
Vancomycin 10  (8.1)  14  (4.7)  0.159  6  (2.4)  0.010
Metronidazole  21  (17.1)  53  (17.6)  0.895  17  (6.8)  0.002
Ceftriaxone 60  (48.8)  107  (35.5)  0.011  78  (31.2)  0.001
Cefepime 2  (1.6)  5  (1.7)  0.979  3  (1.2)  0.737
Cephalothin 2  (1.6) 3  (1)  0.586  17  (6.8)  0.033
Meropenem 27  (22)  68  (22.6)  0.886  19  (7.6)  <0.001
Amikacin 7  (5.7)  18  (6)  0.909  4  (1.6)  0.028
Ciprofloxacin  8  (6.5)  10  (3.3)  0.140  9  (3.6)  0.206
Levofloxacin  3  (2.4)  7  (2.3)  0.944  6  (2.4)  0.982
Piperacillin /  tazobactam  10  (8.1)  20  (6.6)  0.588  8  (3.2)  0.037
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Table  2  (Continued)
Variable  Surgical  patients
with  CDI  (n  =  123)
Surgical  patients
with  diarrhea
and  negative  PCR
(controls-1)
(n  =  301)
p  Surgical
patients  with
no  diarrhea
(controls-2)
(n =  250)
p
Trimethoprim/sulfamethoxazole  1  (0.8)  5  (1.7)  0.502  2  (0.8)  0.989
Fluconazole 5  (4.1)  2  (0.7)  0.013  0  (0)  0.001
Rifampicin 3  (2.4)  9  (3)  0.756  3  (1.2)  0.371
Linezolid 7  (5.7) 32  (10.6)  0.110  7  (2.8)  0.167
Outcome
Associated mortality 6  (4.9) Unknown  Unknown  9  (4.4)
Table  3  Variables  of  importance  in  the  distribution  of  surgical  cases  with  CDI  according  to  ribotype.
Variable  Ribotype  027(n  =  65,  52.8%)  Other  ribotypes(n  =  58,  47.2%)  p
Median  age  (years)  (range)  47  (15-86)  44  (15-86)  0.322
Male 50  (77)  41  (70.7)  0.537
Female 15  (23)  17  (29.3)
Laboratory  test
Bloody  stools,  n  (%)  7  (10.8)  1  (1.7)  0.042
Medications
Immunosuppressants,  n  (%)  5  (7.7)  13  (22.4)  0.021
Amikacin, n  (%)  1  (1.5)  6  (10.3)  0.035
Outcome
Associated death,  n  (%)  2  (3.1)  4  (6.9)  0.382
Table  4  Logistic  regression  analysis  of  the  significant  variables  and  p  value  below  0.02.
Variable  OR  95%  confidence  interval  p
Mucus  in  stools  1.59  1.22  --  2.06  0.001
Fever 1.43  1.08  --  1.88  0.011
Leukocytes in  stools  3.25  2.44  --  4.33  <0.001
Hospitalization  within  the  past  12  weeks  2.08  1.60  --  2.70  <0.001
Antibiotic use  1.37  1.04  --  1.80  0.023
More than  5  days  of  antibiotics  1.55  1.14  --  2.12  0.006
Ceftriaxone  1.46  1.09  --  1.94  0.010
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Discussion
CDI  is  mainly  associated  with  healthcare  services  that  affect
the  adult  population  in  both  the  medical  and  surgical  ser-
vices.  The  authors  of  a  recent  study  stated  that  36%  of  CDI
cases  in  2015  were  patients  with  a  history  of  surgery,  7%  of
which  were  abdominal  surgeries.13
In  our  study,  the  patients  hospitalized  in  the  surgical
services,  especially  in  neurosurgery,  were  documented  as
having  a  high  risk  for  developing  CDI,  as  reported  in  the
literature.
Surgical  patients  are  susceptible  to  exposure  to  the
risk  factors  described  for  the  development  of  CDI  in  the
adult  patient,  which  are  prophylactic  antibiotics,  older  age,
a  higher  number  of  immunosuppressed  patients  requiring
w
1
T0.25  --  0.83  0.011
ransplantation,  orthopedic  procedures  for  prosthesis  place-
ent,  and  intestinal  surgery.2,14--18 The  027  strain  is  linked
o  different  results  in  patients  with  CDI.  According  to  the
esults  of  a  Canadian  multicenter  study  that  included  12  hos-
itals,  the  authors  found  that  the  percentage  of  affected
atients  coming  from  surgical  services  was  below  32.9%,
ompared  with  the  56.1%  from  the  medical  service  wards.
t  should  be  mentioned  that,  for  their  study,  the  C.  difficile
27  strain  was  already  circulating.15
For  example,  in  a  study  that  included  134  hospitals
nd  468,386  procedures,  in  which  CDI  was  looked  for
fter  a  surgery,  a  CDI  rate  of  0.4  per  year  was  found,
ith  differences  between  hospitals  (rates  from  0.04  to
.4%)  and  between  surgical  specialties  (from  0.0  to  2.4%).
he  risk  factors  in  that  study  population  were:  advanced
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ge,  hospitalization  after  surgery,  and  treatment  with  >  3
ntibiotics.16
Knowledge  of  the  particular  risk  factors  for  the  surgical
atient  is  crucial  for  early  diagnosis,  adequate  treatment,
nd  prevention.
The  problem  of  the  association  between  the  patient
ndergoing  neurosurgery  and  CDI  was  recently  reviewed.
hose  patients  are  often  admitted  to  the  intensive  care  unit
or  close  surveillance  due  to  the  diversity  of  complications
hat  can  present  and  are  exposed  to  the  risk  of  devel-
ping  healthcare-associated  infections.  A  total  of  1.9%  of
atients  have  been  reported  to  develop  CDI  after  subarach-
oid  hemorrhage.19
As  in  our  study,  patients  in  cardiac  surgery  services  are
ffected  by  CDI.  They  frequently  present  with  concomi-
ant  diseases,  receive  antibiotics  for  long  periods  of  time,
re  admitted  to  a  specialized  intensive  care  unit,  and
ndergo  procedures  with  multiple  instrumentation.  Inci-
ence  of  CDI  development  in  patients  in  cardiac  surgery  has
een  reported  at  0.75%.9
Surgical  patients  in  the  orthopedics  service  are  at  risk
or  acquiring  CDI  due  to  underlying  disease  and  prolonged
reoperative  hospital  stay.  In  our  study,  those  patients  were
ocumented  as  susceptible  to  developing  CDI.  An  increase  in
DI  and  prophylactic  strategies  employing  amoxicillin  com-
ined  with  clavulanic  acid  in  orthopedic  services  was  an
ffective  decision  for  reducing  the  mortality  rate  by  80%
n  cases  of  CDI.20
Despite  the  fact  that  CDI  is  an  emergent  infection,
ccording  to  the  U.  S.  Centers  for  Disease  Control  (CDC),
ittle  is  known  of  its  epidemiology  in  the  surgical  services
n  Mexico.  In  previous  studies  on  Mexican  patients  with  CDI-
nduced  diarrhea,  the  problem  was  not  specifically  examined
n  surgical  patients.21--25
Compared  with  reports  in  the  medical  literature,  our  sur-
ical  patients  with  CDI  had  a  higher  frequency  of  leukocytes
n  stools  than  the  surgical  patients  with  negative  PCR  (69.9
ersus  47.8%).  The  search  for  leukocytes  in  stools  is  not
ecommended,  given  that  it  has  30%  sensitivity,  74.9%  speci-
city,  13.2%  positive  predictive  value,  and  89.3%  negative
redictive  value,  compared  with  the  enzyme  immunoas-
ay  for  toxin  A  or  B,  signifying  that  a  patient  with  CDI
an  mistakenly  go  untreated  if  the  fecal  leukocyte  test  is
egative.26
Antibiotic  use  was  shown  to  be  a  risk  factor  for  acquir-
ng  CDI  (p  =  0.023)  in  our  study,  and  the  risk  was  greater
f  the  antibiotic  was  administered  for  more  than  5  days
p  = 0.006).  In  addition,  ceftriaxone  was  found  to  be  a
isk  factor  for  developing  CDI  in  the  surgical  services  (OR:
.46,  p  =  0.010).  Those  findings  have  been  well-studied
nd  there  are  programs  on  adequate  antibiotic  use  in
urgical  services  to  control  CDI.  Not  using  preoperative
rophylaxis  with  antimicrobials,  eliminating  the  use  of
ntibiotics  that  are  high-risk  for  CDI,  and  using  low-risk
ntibiotics,  such  as  amoxicillin  with  clavulanic  acid,  has
een  proposed.12,20,27,28
A  common  finding  has  been  the  use  of  proton  pump
nhibitors,  which  in  our  study  were  administered  in  90.2%
f  the  surgical  cases  of  CDI  versus  78.8%  of  the  controls-
 (p  =  0.006),  suggesting  that  the  use  of  H2  antagonists  or
roton  pump  inhibitors  should  be  reduced.6,8,29,30R.  Morfín-Otero  et  al.
The  above-stated  results  on  risk  factors  could  be  con-
idered  comparable  to  those  from  a  study  on  a  Mexican
opulation  with  CDI  by  Pérez-Topete  et  al.  They  reported  the
revious  use  of  antibiotics  (83%)  and  the  use  of  PPIs  (54%),
s  the  main  risk  factors  for  CDI.  The  most  commonly  used
ntibiotic  in  their  study  was  ciprofloxacin.  However,  they
id  not  discriminate  between  community-acquired  CDI  and
ospital-acquired  infection  and  the  sample  size  was  small
n  =  55).31
Education,  especially  about  the  risk  factors  for  CDI,
s  important  for  controlling  said  nosocomial  infection.
mplementing  programs  for  adequate  antimicrobial  use
Antimicrobial  Stewardship)  in  surgical  services  to  con-
rol  CDI  is  frequently  discussed.32 In  addition,  there  are
umerous  guidelines  that  provide  recommendations  for  the
revention  and  control  of  CDI.  In  2007,  in  the  United  King-
om,  the  ‘‘High  Impact  Intervention  No.  7’’  care  bundle
ame  out  and  its  measures,  such  as  rational  antimicrobial
se  and  contact  precautions  as  basic  strategies,  were  later
eiterated  in  European  and  U.S.  guidelines.33
The  participation  of  surgical  services  is  indispensable
or  implementing  strategies  to  combat  CDI,  such  as  early
urgical  management,  adequate  application  of  antimicro-
ial  prophylaxis  in  surgery,  and  consensus  guidelines  on  the
iagnosis  and  management  of  CDI  in  their  communities.34--38
everal  Mexican  authors  have  commented  on  the  above  in  in
n  attempt  to  raise  awareness,  and  different  articles  have
tressed  the  obligation  physicians  have  to  increase  their
nowledge  of  CDI  and  practice  strict  surveillance  of  the
igh-risk  population.  In  other  words,  it  is  time  for  us  to  be
oncerned  about  C.  difficilein  Mexico.39
Among  the  limitations  of  the  present  study  was  the  lack
f  cultures  for  C.  difficile,  the  limited  use  of  colonic  imag-
ng,  colonoscopy,  and  autopsies.  Another  limitation  was  not
nowing  the  etiology  of  hospital-acquired  diarrhea  that  was
egative  for  C.  difficile  and  that  could  have  been  secondary
o  other  conditions,  such  as  osmotic  diarrhea  (caused  by
ube  feeding)  or  drug-induced  diarrhea.
onclusions
n  conclusion,  patients  hospitalized  in  the  surgical  services
f  our  hospital,  especially  in  neurosurgery,  presented  with
 high  risk  for  developing  CDI.  The  present  study  confirmed
revious  antibiotic  use,  antibiotic  use  longer  than  5  days,
eftriaxone  use,  and  prior  hospitalization  as  risk  factors  for
cquiring  CDI.
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